Jyong Biotech Ltd. (MENS) — SEC Filings
Jyong Biotech Ltd. (MENS) — 1 SEC filings. Latest: 6-K (Jun 20, 2025). Includes 1 6-K.
View Jyong Biotech Ltd. on SEC EDGAR
Overview
Jyong Biotech Ltd. (MENS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Jun 20, 2025: On June 16, 2026, Jyong Biotech Ltd. entered into an underwriting agreement with Joseph Stone Capital, LLC, acting as the representative for the underwriters. This agreement outlines the terms for the company's initial public offering (IPO).
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Jyong Biotech Ltd. is neutral.
Filing Type Overview
Jyong Biotech Ltd. (MENS) has filed 1 6-K with the SEC between Jun 2025.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| Jun 20, 2025 | 6-K | Jyong Biotech Ltd. Files 6-K for IPO Underwriting Agreement | medium |
Risk Profile
Risk Assessment: Of MENS's 1 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 0 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Top Tags
ipo (1) · underwriting-agreement (1) · public-offering (1)
Frequently Asked Questions
What are the latest SEC filings for Jyong Biotech Ltd. (MENS)?
Jyong Biotech Ltd. has 1 recent SEC filings from Jun 2025, including 1 6-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MENS filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Jyong Biotech Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Jyong Biotech Ltd. (MENS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Jyong Biotech Ltd.?
Financial highlights for Jyong Biotech Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for MENS?
Investment thesis data for MENS will be available once enriched filings are processed.
Who are the key executives at Jyong Biotech Ltd.?
Executive information for Jyong Biotech Ltd. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Jyong Biotech Ltd. stock?
Of MENS's 1 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Jyong Biotech Ltd.?
Forward guidance and predictions for Jyong Biotech Ltd. are extracted from SEC filings as they are enriched.